Jeet Mukherjee
Stock Analyst at BTIG
(3.89)
# 1,811
Out of 4,444 analysts
120
Total ratings
48.4%
Success rate
9.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTH Faeth Therapeutics | Maintained: Buy | $55 | $24.00 | +129.17% | 2 | Jun 15, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $30 → $32 | $18.86 | +69.67% | 11 | Jun 11, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $104 | $81.77 | +27.19% | 14 | Jun 1, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $42 | $33.74 | +24.48% | 2 | May 29, 2026 | |
| AARD Aardvark Therapeutics | Downgraded: Hold | n/a | $4.23 | - | 9 | May 15, 2026 | |
| ARVN Arvinas | Reiterated: Buy | $16 → $18 | $8.14 | +121.13% | 12 | May 13, 2026 | |
| IPHA Innate Pharma | Maintained: Buy | $8 | $1.90 | +321.05% | 4 | May 13, 2026 | |
| AAPG Ascentage Pharma Group International | Maintained: Buy | $48 | $17.01 | +182.19% | 4 | May 13, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $14 | $3.00 | +366.67% | 9 | May 12, 2026 | |
| BCAX Bicara Therapeutics | Reiterated: Buy | $28 | $25.00 | +12.00% | 5 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $18 | $4.21 | +327.55% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $12 | $7.32 | +63.93% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $34.81 | +259.09% | 5 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 | $118.63 | +81.24% | 8 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $4.15 | +165.06% | 4 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $138 | $98.25 | +40.46% | 12 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.38 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $91 | $29.30 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $0.921 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $48.60 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $14.91 | n/a | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.57 | n/a | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $34.91 | n/a | 1 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.008 | n/a | 1 | Apr 1, 2025 |
Faeth Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $55
Current: $24.00
Upside: +129.17%
Nurix Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: $30 → $32
Current: $18.86
Upside: +69.67%
Monopar Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $104
Current: $81.77
Upside: +27.19%
ArriVent BioPharma
May 29, 2026
Maintained: Buy
Price Target: $42
Current: $33.74
Upside: +24.48%
Aardvark Therapeutics
May 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.23
Upside: -
Arvinas
May 13, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $8.14
Upside: +121.13%
Innate Pharma
May 13, 2026
Maintained: Buy
Price Target: $8
Current: $1.90
Upside: +321.05%
Ascentage Pharma Group International
May 13, 2026
Maintained: Buy
Price Target: $48
Current: $17.01
Upside: +182.19%
Perspective Therapeutics
May 12, 2026
Reiterated: Buy
Price Target: $14
Current: $3.00
Upside: +366.67%
Bicara Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $28
Current: $25.00
Upside: +12.00%
May 8, 2026
Maintained: Buy
Price Target: $19 → $18
Current: $4.21
Upside: +327.55%
May 8, 2026
Maintained: Buy
Price Target: $13 → $12
Current: $7.32
Upside: +63.93%
May 1, 2026
Reiterated: Buy
Price Target: $125
Current: $34.81
Upside: +259.09%
Apr 1, 2026
Reiterated: Buy
Price Target: $215
Current: $118.63
Upside: +81.24%
Mar 11, 2026
Maintained: Buy
Price Target: $11
Current: $4.15
Upside: +165.06%
Feb 3, 2026
Maintained: Buy
Price Target: $138
Current: $98.25
Upside: +40.46%
May 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $10.38
Upside: n/a
May 23, 2025
Maintained: Buy
Price Target: $91
Current: $29.30
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: $12
Current: $0.921
Upside: n/a
May 13, 2025
Initiated Coverage: Buy
Price Target: $42
Current: $48.60
Upside: n/a
May 9, 2025
Maintained: Buy
Price Target: $100
Current: $14.91
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $10
Current: $3.57
Upside: n/a
Apr 14, 2025
Maintained: Buy
Price Target: $62
Current: $34.91
Upside: n/a
Apr 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.008
Upside: n/a